Balchem Stock Today
| BCPC Stock | USD 170.76 2.62 1.56% |
PerformanceGood
| Odds Of DistressTiny
|
Balchem is trading at 170.76 as of the 30th of January 2026, a 1.56% increase since the beginning of the trading day. The stock's open price was 168.14. Balchem has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 1st of November 2025 and ending today, the 30th of January 2026. Click here to learn more.
Business Domain Materials | IPO Date 3rd of June 1986 | Category Basic Materials |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company has 32.39 M outstanding shares of which 347.87 K shares are currently shorted by private and institutional investors with about 1.76 trading days to cover. More on Balchem
Moving together with Balchem Stock
Moving against Balchem Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Balchem Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Theodore Harris | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Specialty Chemicals, Basic Materials, SP Small-Cap 600, Nasdaq Industrial, NASDAQ Composite, NASDAQ Composite Total, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBy employing borrowed capital, Balchem can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Balchem's use of financial leverage and reveals what portion of Balchem's asset base relies on creditor financing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balchem (BCPC) is traded on NASDAQ Exchange in USA and employs 1,355 people. Balchem is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.54 B. Balchem conducts business under Chemicals sector and is part of Materials industry. The entity has 32.39 M outstanding shares of which 347.87 K shares are currently shorted by private and institutional investors with about 1.76 trading days to cover.
Balchem currently holds about 58.1 M in cash with 182 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
Check Balchem Probability Of Bankruptcy
Ownership AllocationBalchem holds a total of 32.39 Million outstanding shares. The majority of Balchem outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Balchem to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Balchem. Please pay attention to any change in the institutional holdings of Balchem as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Balchem Ownership Details
Balchem Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2025-06-30 | 451.7 K | |
| Schroder Investment Management Group | 2025-06-30 | 407.5 K | |
| Northern Trust Corp | 2025-06-30 | 395.5 K | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 368.5 K | |
| Congress Asset Management Company, Llp | 2025-06-30 | 362.1 K | |
| Grantham, Mayo, Van Otterloo & Co., Llc | 2025-06-30 | 352.5 K | |
| Nuveen, Llc | 2025-06-30 | 345.5 K | |
| Clearbridge Advisors, Llc | 2025-06-30 | 335.8 K | |
| Stephens Inv Mgmt Group Llc | 2025-06-30 | 275.4 K | |
| Blackrock Inc | 2025-06-30 | 4.9 M | |
| Vanguard Group Inc | 2025-06-30 | 3.9 M |
Balchem Historical Income Statement
Balchem Stock Against Markets
Balchem Corporate Management
| Hatsuki Miyata | General VP | Profile | |
| William CPA | VP Officer | Profile | |
| Frederic Boned | Senior Health | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Brent Tignor | Senior Officer | Profile | |
| George Graham | Senior Officer | Profile | |
| Carl Bengtsson | CFO Treasurer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Specialty Chemicals sector continue expanding? Could Balchem diversify its offerings? Factors like these will boost the valuation of Balchem. Projected growth potential of Balchem fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Balchem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.204 | Dividend Share 0.87 | Earnings Share 4.58 | Revenue Per Share | Quarterly Revenue Growth 0.115 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Balchem's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Balchem should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Balchem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.